Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.67M Buy
6,636
+3,891
+142% +$930K 0.05% 125
2024
Q3
$604K Buy
+2,745
New +$532K 0.02% 335
2024
Q1
Sell
-30,000
Closed -$5.37M 492
2023
Q4
$5.37M Buy
+30,000
New +$4.89M 0.28% 58
2023
Q3
Sell
-3,110
Closed -$455K 477
2023
Q2
$455K Sell
3,110
-5,480
-64% -$779K 0.07% 279
2023
Q1
$1.25M Buy
8,590
+2,347
+38% +$339K 0.19% 110
2022
Q4
$896K Sell
6,243
-3,032
-33% -$444K 0.06% 135
2022
Q3
$1.34M Buy
9,275
+4,543
+96% +$719K 0.18% 65
2022
Q2
$724K Buy
+4,732
New +$823K 0.07% 193
2021
Q4
Sell
-1,221
Closed -$243K 595
2021
Q3
$243K Sell
1,221
-1,735
-59% -$347K 0.03% 366
2021
Q2
$552K Buy
+2,956
New +$569K 0.06% 155
2017
Q2
Sell
-2,800
Closed -$399K 498
2017
Q1
$399K Buy
+2,800
New +$399K ﹤0.01% 310

Other funds holding FFIV

Caxton Associates (New York)'s FFIV Position: Q4 2024 in Review

Caxton Associates (New York) increased its F5 (FFIV) stake by 142% in Q4 2024, buying an estimated $930K and bringing the position to 6,636 shares worth $1.67M. The position accounts for 0.05% of the portfolio, ranked #125.

Caxton Associates (New York) first reported a position in FFIV in Q1 2017 and has held it in 11 quarters since. The position peaked at $5.37M in Q4 2023. 644 funds tracked by Wall St. Rank hold FFIV as of Q4 2024.

  • Caxton Associates (New York) held 6,636 shares of F5 worth $1.67M as of Q4 2024.
  • Caxton Associates (New York) bought 3,891 F5 shares in Q4 2024, an estimated $930K.
  • F5 made up 0.05% of Caxton Associates (New York)'s portfolio in Q4 2024, its #125 holding.
  • Caxton Associates (New York) first reported a position in F5 in Q1 2017 and has held it in 11 quarters since.
  • Caxton Associates (New York)'s F5 position peaked at $5.37M in Q4 2023.
  • 644 funds tracked by Wall St. Rank held F5 as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.